4/7/2024 0 Comments Profound ai icadAt the NCoBC Interdisciplinary Breast Center Conference, Mark Traill, MD, University of Michigan Health, presented findings from a study titled “Correlation between BI-RADS Assessment Categories and Artificial Intelligence Case Scores,” which was a winner in the “Breast Disease Diagnosis and Management” category.Īccording to study findings presented by Dr. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that new research supporting the clinical value of ProFound AI® for Digital Breast Tomosynthesis (DBT) was presented at the Society of Breast Imaging (SBI) Symposium, April 9-11, and at the National Consortium of Breast Centers (NCBC) Annual Interdisciplinary Breast Center Conference (NCoBC), April 16-19.Įmily Conant, MD, Professor and Division Chief of Breast Imaging at the University of Pennsylvania Medical Center, presented findings from a retrospective analysis involving ProFound AI for DBT in a presentation titled “Feasibility of automated identification of low-likelihood of cancer cases in digital breast tomosynthesis screening,” at the SBI Symposium. NASHUA, N.H., Ap(GLOBE NEWSWIRE) - iCAD, Inc. Studies presented at two leading breast imaging conferences demonstrate ProFound AI helps radiologists identify normal mammograms and those with increased likelihood of malignancy with precision
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |